The US Food and Drug Administration (FDA) late Wednesday approved the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results